Assyro AI
FDA 483 Database

FDA Form 483s Issued in August 2025

Every published Form FDA 483 issued in August 2025, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

10

Published 483s in August 2025

10

Distinct firms

Form 483s issued in August 2025

Molecular PharmaGroup LLCFDA
FEI
3014413265
Issued
Aug 11, 2025
Establishment
Outsourcing Facility
Location
New Jersey, United States
Zydus Lifesciences LimitedFDA
FEI
3005430968
Issued
Aug 13, 2025
Establishment
Drug Manufacturer
Location
India
Sumitomo Pharma Co., Ltd.FDA
FEI
3003028650
Issued
Aug 7, 2025
Establishment
Drug Manufacturer
Location
Japan
RC Outsourcing LLCFDA
FEI
3011967886
Issued
Aug 28, 2025
Establishment
Outsourcing Facility
Location
Ohio, United States
Nephron Sc IncFDA
FEI
3010892830
Issued
Aug 22, 2025
Establishment
Sterile Drug Manufacturer
Location
South Carolina, United States
Cohance Lifesciences LimitedFDA
FEI
3008768274
Issued
Aug 12, 2025
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Fagron Compounding ServicesFDA
FEI
3012104093
Issued
Aug 8, 2025
Establishment
Outsourcing Facility
Location
Kansas, United States
Olympia PharmaceuticalsFDA
FEI
3009724085
Issued
Aug 8, 2025
Establishment
Outsourcing Facility
Location
Florida, United States
AnazaoHealth CorporationFDA
FEI
3011152407
Issued
Aug 8, 2025
Establishment
Outsourcing Facility
Location
Nevada, United States
Hikma Injectables USA Inc.FDA
FEI
3022897129
Issued
Aug 8, 2025
Establishment
Outsourcing Facility
Location
New Jersey, United States

Other months in 2025

Back to the FDA 483 Database